Is the 5-HT7 receptor involved in the pathogenesis and prophylactic treatment of migraine?

European Journal of Pharmacology

Volumn 439, Issue 1-3, 2002, Pages 1-11

  Terrón, José A ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT7 receptor; Migraine pathogenesis; Prophylactic drug

Indexed keywords

5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; ALPHA METHYLSEROTONIN; AMITRIPTYLINE; CHLORPROMAZINE; CLOZAPINE; CYPROHEPTADINE; DIHYDROERGOTAMINE; ENDOTHELIUM DERIVED RELAXING FACTOR; LISURIDE; MESSENGER RNA; MESULERGINE; METHYSERGIDE; METITEPINE; MIANSERIN; N (2 HYDROXYCYCLOPENTYL) 1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXAMIDE; NITRIC OXIDE; PIZOTIFEN; PROTEIN KINASE INHIBITOR; RECEPTOR SUBTYPE; RESERPINE; RITANSERIN; SEROTONIN; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SPIPERONE; SUMATRIPTAN;

BLOOD VESSEL INNERVATION; BRAIN BLOOD VESSEL; BRAIN MICROCIRCULATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; MIGRAINE; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; VASODILATATION;

EID: 0037192581     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01436-X     Document Type: Article

References (126)

1. Cerebral perivascular serotonergic fibres have a peripheral origin in the gerbil
2. Plasma serotonin in migraine and stress
3. 7) positively linked to adenylate cyclase
4. Migraine in school children
5. Migraine pathogenesis: The neural hypothesis re-examined
6. 7 receptor affinity and protection against sound-induced seizures in DBA/2J mice
7. Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine
8. The biochemistry of migraine
9. 1-like receptors mediating vasoconstriction and vasodilatation: Their characterization and distribution in the intact canine cardiovascular system
10. Serotonergic modulation of hyperpolarization-activated current in isolated rat dorsal root ganglion neurons
11. Seasonal and circadian monoamine variations in human brain examined post mortem
12. Nerves containing serotonin, its interaction with noradrenaline and characterization of serotonergic receptors in cerebral arteries of monkey
13. Evidence for coexistence of serotonin and noradrenaline in sympathetic nerves supplying vessels of guinea-pig
14. Serotonin uptake into cerebrovascular nerve fibres of rat, visualization by immunohistochemistry, disappearance following sympathectomy, and release during electrical stimulation
15. Origin and postnatal development of nerves showing 5-hydroxytryptamine-like immunoreactivity supplying major cerebral arteries of rat
16. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects
17. Relationships between headache and amine changes after administration of reserpine to migrainous patients
18. 7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery
19. Lisuride as a migraine prophylactic in children: An open clinical trial
20. Central serotonergic nerves project to the pial vessels of the brain
21. 1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice
22. Serotonin, migraine and platelets
23. 1C receptor agonism as an initiating event in migraine
24. The 5-hydroxytryptamine-nitric oxide connection: The key link in the initiation of migraine?
25. 1C receptor activation: A key step in the initiation of migraine?
26. 5-Hydroxytryptamine (5-HT) and the initiation of migraine: New perspectives
27. Il lisuride maleato acido nella profilassi della cefalea emicranica
28. Cerebral blood flow changes in migraine: Methods, observations and hypotheses
29. Migraine pain associated with middle cerebral artery dilatation: Reversal by sumatriptan
30. Concentration of serotonin in blood platelets: Effect of reserpine in migraineurs
31. Dorsal raphe nuclear stimulation of suprachiasmatic nucleus serotonin release and circadian phase-resetting
32. 1C-like receptors
33. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine
34. Amitriptyline in migraine prophylaxis
35. Serotonergic parallels in migraine, depression and anxiety
36. Mechanism of migraine headache and action of ergotamine tartrate
37. Immunohistochemical demonstration of serotonin in nerves supplying human cerebral and mesenteric blood vessels: Some speculations about their involvement in vascular disorders
38. Serotonin as a neurotransmitter in cerebral arteries
39. 5-Hydroxytryptamine involvement in migraine
40. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission. A new hypothesis
41. Clinical effectiveness of lisuride hydrogen maleate: A double-blind trial versus methysergide
42. Effects of light and aging on the human suprachiasmatic nucleus
43. Suprachiasmatic nucleus of the human brain: An immunocytochemical and morphometric analysis
44. Protective effect of serotonin on migraine attacks
45. 1 recognition sites
46. 5-Hydroxytryptamine and the pathophysiology of migraine
47. Mode of action of the anti-migraine drug sumatriptan
48. Serotonin 5-HT(7) receptors mediate relaxation of porcine pial veins
49. Structure and function of the brain serotonergic system
50. 2C receptor blockade?
51. Effect of serotonin in migraine patients
52. Cerebrospinal fluid (CSF) investigations in migraine
53. Comparative trial of serotonin antagonists in the management of migraine
54. Nitric oxide synthase inhibition in migraine
55. Nitric oxide synthase inhibition: A new principle in the treatment of migraine attacks
56. Serotonin relaxes porcine pial veins
57. Diurnal rhythms in neurochemical-neuroendocrine systems controlling nutrient intake and energy metabolism
58. Ergotamine tartrate and dihydroergotamine mesylate: Safety profiles
59. 7) implicated in the regulation of mammalian circadian rhythms
60. 2 receptors mediating vascular smooth muscle contraction
61. Investigations into migraine pathogenesis: Time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC)
62. The trigeminovascular system in humans: Pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation
63. Mianserin in the prophylaxis of migraine: A double-blind study
64. Visual afferents and suprachiasmatic nucleus pacemaker function
65. The neurobiology of vascular head pain
66. Sensory connections to cephalic blood vessels and their possible importance to vascular headaches
67. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
68. Raphé origin of serotonin-containing neurons within choroid plexus of the rat
69. 2 receptor antagonists and migraine therapy
70. Hormone changes in headache disorders
71. 2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs. amitriptyline
72. Focal headache during balloon inflation in the internal carotid and middle cerebral arteries
73. Nitric oxide is a key molecule in migraine and other vascular headaches
74. Present and future of 5-HT receptor agonists as antimigraine drugs
75. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase
76. Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation
77. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study
78. 5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: A polymerase chain reaction study
79. 7 receptors mediating relaxation of human colonic circular smooth muscle
80. 1B/1D agonist zolmitriptan (311C90, Zomig)
81. Hypothalamic-pituitary-adrenal axis studies in migraine with special reference to insulin sensitivity
82. Serotonin neurons project to small blood vessels in the brain
83. 2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
84. 7) activating cAMP formation
85. Sleep and headache syndromes: A clinical review
86. A putative 5-HT central feedback in migraine and cluster headache attacks
87. Migraine: II. Treatment
88. The effects of antimigraine drugs on the vascular responses by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: Possible pharmacological implications to their antimigraine action
89. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine - Studies in an experimental model for migraine
90. 1-like receptor agonists and the pathophysiology of migraine
91. Neurochemical studies on the existence, origin and characteristics of the serotonergic innervation of small pial vessels
92. 2B receptors: An early step in the generation of migraine headache?
93. Dihydroergotamine: A review of its use in the treatment of migraine and other headaches
94. 7 serotonin receptor subtype
95. Biochemical investigations in headache: Increase in the hydroxyindoleacetic acid excretion during migraine attacks
96. Advances in understanding the pathophysiology of headache
97. The significance of blood serotonin levels in migraine. A critical review
98. Migraine prophylaxis with lisuride hydrogen maleate. A double-blind study of lisuride versus placebo
99. Characterization of 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava
100. Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava
101. 5-HT, peripheral and central receptors and function
102. Migraine headache and blood serotonin levels after administration of zimelidine, a selective inhibitor of serotonin uptake
103. Mediation of serotonin hyper-algesia by the cAMP second messenger system
104. 7 receptor mediating direct relaxation to 5-hydroxytryptamine in canine cerebral blood vessels
105. 7 receptor in cerebrovascular vasodilatation: Potential impact in migraine
106. 7 receptor: A target for novel therapeutic avenues? I
107. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries
108. 5-HT(7) receptor mRNA expression in human trigeminal ganglia
109. Antiserotonin drugs in migraine prophylaxis
110. Treatment of migraine attacks with sumatriptan
111. 2B receptor
112. 7 receptors in guinea-pig brain
113. 5-Carboxamidotryptamine: A potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava
114. Analysis of cranial artery pulse waves in patients with vascular headaches of migraine type
115. Studies on headache: Long term observations on the reactivity of the cranial arteries in subjects with vascular headache of the migraine type
116. 1-like receptor subtype mediates cAMP synthesis in porcine pial vein
117. Expression of serotonin receptor mRNAs in blood vessels
118. 7 receptor
119. 2B receptor: Evidence for species differences
120. Intensity dependence of auditory evoked potentials is pronounced in migraine: An indication of cortical potentiation and low serotonergic neurotransmission
121. Brain stem activation in spontaneous human migraine attacks
122. Clinical features of migraine
123. Pharmacology of the autonomic nervous system
124. Role of the suprachiasmatic nucleus in the pathogenesis of migraine